Tethys Investments

Tethys Investments focuses on lower-middle-markets and undertakes growth and distressed-assets investing in Eurasia. We don't invest in industries and companies where we don't know the mechanics and potential of value creation. We consider debt and equity capital options for identified great-value investments. Our investment decision making framework in Eurasia is based on 4 key tenets: (1) regional and country specialization, (2) industry expertise, & (3) rigorous due diligence including quantitative investment analysis & (4) field intensive qualitative analysis. We seek investment opportunities that result in stronger companies that employ the best people in the industry and region, are socially responsible, and deliver strong returns over the long-term. Whenever our analysis demonstrates viable exit options within 5-10 year term, Tethys Investments can invest in greenfield projects.

Ramil Maharramov Muzaffarsky

Managing Partner

6 past transactions

Ceva Santé Animale

Private Equity Round in 2025
Ceva Santé Animale S.A. specializes in the research, development, production, and marketing of veterinary pharmaceuticals and vaccines for both companion and farm animals. The company provides a diverse range of products, including treatments for behavior, cardiology, nephrology, dermatology, locomotion, parasitology, and reproduction management for companion animals. For farm animals, Ceva offers anti-infective products, vaccines, and reproductive management solutions for cattle, sheep, goats, swine, and poultry. Additionally, the company has developed tools such as the Ceva Lung Program, a mobile application that helps manage lung health in livestock. Established in 1988 and headquartered in Libourne, France, Ceva operates pharmaceutical and research facilities in various countries, including Canada, Brazil, Italy, Hungary, the United States, Japan, Mexico, China, and Canada. The company is actively involved in global welfare initiatives, collaborating with local organizations to enhance animal health and welfare.

Septeo

Private Equity Round in 2024
Septeo Group specializes in providing legal technology services to notaries, law firms, corporate legal departments, and real estate property managers. The company offers a range of solutions, including infrastructure management, digital communication, enterprise resource planning (ERP) software, managed cloud services, and outsourcing facilities. By delivering relevant tools and services, Septeo aims to simplify operations for its clients, allowing them to concentrate on their core business activities. The organization is structured to enhance the expertise of each company within the group, ensuring exceptional service delivery to its customers.

The ROW

Private Equity Round in 2024
The ROW is a New York-based organization that specializes in designing, manufacturing, and providing a diverse range of ready-to-wear clothing and accessories. The company focuses on offering high-quality products, including ready-to-wear apparel, eyewear, handbags, and footwear for women, men, and children. Known for its emphasis on fine fabrics and an ideal fit, The ROW aims to deliver stylish and sophisticated options to its customers.

Sezane

Venture Round in 2022
Sezane Manufacturer of clothes and accessories in France.

Ceva Santé Animale

Venture Round in 2020
Ceva Santé Animale S.A. specializes in the research, development, production, and marketing of veterinary pharmaceuticals and vaccines for both companion and farm animals. The company provides a diverse range of products, including treatments for behavior, cardiology, nephrology, dermatology, locomotion, parasitology, and reproduction management for companion animals. For farm animals, Ceva offers anti-infective products, vaccines, and reproductive management solutions for cattle, sheep, goats, swine, and poultry. Additionally, the company has developed tools such as the Ceva Lung Program, a mobile application that helps manage lung health in livestock. Established in 1988 and headquartered in Libourne, France, Ceva operates pharmaceutical and research facilities in various countries, including Canada, Brazil, Italy, Hungary, the United States, Japan, Mexico, China, and Canada. The company is actively involved in global welfare initiatives, collaborating with local organizations to enhance animal health and welfare.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.